1966 - Fellow of the American Association for the Advancement of Science (AAAS)
The scientist’s investigation covers issues in Biochemistry, Photosensitizer, Molecular biology, Internal medicine and Photodynamic therapy. His Biochemistry study integrates concerns from other disciplines, such as Protoporphyrin IX and Hematoporphyrin. He works mostly in the field of Photosensitizer, limiting it down to concerns involving Singlet oxygen and, occasionally, Biophysics.
His Molecular biology research is multidisciplinary, incorporating perspectives in DNA, Estrogen receptor, Estrogen receptor alpha, Intracellular and Transcription. His research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with issues in Fibroadenoma and Dehydrogenase. He has included themes like Oxygen and In vivo in his Photodynamic therapy study.
His main research concerns Internal medicine, Endocrinology, Biochemistry, Estrogen and Estrogen receptor. His Prolactin study, which is part of a larger body of work in Internal medicine, is frequently linked to 7,12-Dimethylbenz[a]anthracene, bridging the gap between disciplines. His Endocrinology research is multidisciplinary, incorporating elements of Receptor and Mammary tumor.
His Biochemistry research includes themes of Molecular biology and Photodynamic therapy, Hematoporphyrin. He combines subjects such as Androgen and Uterus with his study of Estrogen. His Estrogen receptor research incorporates themes from Transcription and Cell biology.
Russell Hilf focuses on Photosensitizer, Estrogen receptor, Biochemistry, Photodynamic therapy and Estrogen. The study incorporates disciplines such as Singlet oxygen, Medicinal chemistry and Phototoxicity in addition to Photosensitizer. He interconnects Transcription and Cell biology in the investigation of issues within Estrogen receptor.
He is involved in the study of Biochemistry that focuses on Transfection in particular. His Photodynamic therapy study combines topics from a wide range of disciplines, such as Porphobilinogen deaminase and Mitochondrion. His Estrogen receptor alpha research incorporates elements of Nuclear receptor and Endocrinology.
Russell Hilf spends much of his time researching Photosensitizer, Estrogen receptor, Biochemistry, Cell biology and Organic chemistry. His Photosensitizer research is multidisciplinary, relying on both Singlet oxygen and Photodynamic therapy. His study on Biochemistry is mostly dedicated to connecting different topics, such as Protoporphyrin IX.
The concepts of his Cell biology study are interwoven with issues in Estrogen signaling, Nucleotide and Cofactor. His work on Pyrrole and Diastereomer as part of general Organic chemistry study is frequently linked to Benzaldehyde, bridging the gap between disciplines. His work in Estrogen receptor beta addresses issues such as Nuclear receptor, which are connected to fields such as Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A fluorometric method for determination of oxidized and reduced glutathione in tissues.
Paul J. Hissin;Russell Hilf.
Analytical Biochemistry (1976)
Oxygen consumption and diffusion effects in photodynamic therapy.
Thomas H. Foster;Richards S. Murant;Robert G. Bryant;Robert S. Knox.
Radiation Research (1991)
Sequence Requirements for Estrogen Receptor Binding to Estrogen Response Elements
Mark D. Driscoll;G. Sathya;Mesut Muyan;Carolyn M. Klinge.
Journal of Biological Chemistry (1998)
Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors.
Russell Hilf;Richard S. Murant;Uma Narayanan;Scott L. Gibson.
Cancer Research (1986)
Single-Chain Estrogen Receptors (ERs) Reveal that the ERα/β Heterodimer Emulates Functions of the ERα Dimer in Genomic Estrogen Signaling Pathways
Xiaodong Li;Jing Huang;Ping Yi;Robert A. Bambara.
Molecular and Cellular Biology (2004)
Fluence Rate Effects in Photodynamic Therapy of Multicell Tumor Spheroids
Thomas H. Foster;Donna F. Hartley;Michael G. Nichols;Russell Hilf.
Cancer Research (1993)
Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Zhongxue Hua;Scott L. Gibson;Thomas H. Foster;Russell Hilf.
Cancer Research (1995)
Specific Estrogen-binding Capacity of the Cytoplasmic Receptor in Normal and Neoplastic Breast Tissues of Humans
James L. Wittliff;Russell Hilf;William F. Brooks;Edwin D. Savlov.
Cancer Research (1972)
BIOCHEMICAL AND MORPHOLOGIC PROPERTIES OF A NEW LACTATING MAMMARY TUMOR LINE IN THE RAT.
Russell Hilf;Inge Michel;Carlton Bell;James J. Freeman.
Cancer Research (1965)
Photosensitization of Mitochondrial Cytochrome c Oxidase by Hematoporphyrin Derivative and Related Porphyrins in Vitro and in Vivo
Scott L. Gibson;Russell Hilf.
Cancer Research (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Rochester
University of Louisville
University at Buffalo, State University of New York
University of Rochester Medical Center
University of New Mexico
Boston University
University of Missouri
University of Rochester
University at Buffalo, State University of New York
University of Delhi
University of Geneva
National Research Council (CNR)
Vienna University of Economics and Business
World Bank
Google (United States)
South China University of Technology
Texas Tech University
University at Buffalo, State University of New York
Ghent University
University of California, Davis
Spanish National Research Council
University of East Anglia
University Medical Center Groningen
University of Maryland, Baltimore
Université Paris Cité
Royal College of Surgeons in Ireland